Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | SCN9A | Q15858 | 11/20 | 0.44 |
| ▸ | BRD4 | O60885 | 1/20 | 0.42 |
| ▸ | PDE4A | P27815 | 1/20 | 0.41 |
| ▸ | AGO2 | Q9UKV8 | 1/20 | 0.41 |
| ▸ | EDNRA | P25101 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11651032 | 0.80 | POLB (0.55) | ALDH1A1MAPTADRA1ASCN9ABRD4 | |
| SCHEMBL11661464 | 0.80 | POLB (0.55) | ALDH1A1MAPTADRA1ASCN9ABRD4 | |
| SCHEMBL8065430 | 0.80 | ALDH1A1 (0.44) | ALDH1A1MAPTADRA1ASCN9ABRD4 | |
| SCHEMBL7093262 | 0.79 | MAPT (0.59) | ALDH1A1MAPTADRA1APDE4AAGO2 | |
| SCHEMBL11661462 | 0.78 | MAPT (0.57) | ALDH1A1MAPTADRA1APDE4AAGO2 | |
| SCHEMBL11752886 | 0.77 | ALDH1A1 (0.41) | ALDH1A1MAPTADRA1ASCN9ABRD4 | |
| SCHEMBL3477694 | 0.72 | BRD4 (0.52) | ALDH1A1SCN9ABRD4EDNRAMEN1 | |
| SCHEMBL19414342 | 0.71 | SCN9A (0.46) | SCN9ABRD4 | |
| SCHEMBL29812001 | 0.71 | SCN9A (0.56) | SCN9ABRD4MEN1KMT2A | |
| SCHEMBL11623601 | 0.71 | LMNA (0.59) | ALDH1A1MAPTMEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4833132-A | 5-METHYL-3-SULFANILAMIDOISOOXAZOLE OR SALTS OR 2,4 DIAMINO PYRIMIDINE COMPOUNDS | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 1989-05-23 | — | — | US | claimed |
| US-4698335-A | Process for treating a warm-blooded animal to be subjected to radiotherapy | UNIVERSITY OF MEDICINE & DENTISTRY OF NEW JERSEY (US) | 1987-10-06 | — | — | US | claimed |
| US-4661478-A | ADMINISTERING 5-METHYL-3-SULFANILAMIDO-ISOXAZOLE AND 2,4-DIAMINO-5-(3,4,5-TRIMETHOXYBENZYL) PYRIMIDINE | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 1987-04-28 | — | — | US | claimed |
| US-4632919-A | ANTICOAGULANTS | UNIVERSITY OF MEDICINE & DENTISTRY OF N.J. (US) | 1986-12-30 | — | — | US | claimed |
| US-4632920-A | 5-METHYL-3-SULFANILAMIDOISOXAZOLE AND 2,4-DIAMINO 5-(3,4,5-TRIMETHOXYBENZYL)PYRIMIDINE | UNIVERSITY OF MEDICINE & DENTISTRY OF NEW JERSEY (US) | 1986-12-30 | — | — | US | claimed |
| US-6057359-A | NEW ESTERS OF BACCATIN-III, 10-DEACETYLBACCATIN-III AND 14-OH-10-DEACETYLBACCATIN-III USED FOR THE TREATMENT OF ECZEMA, PSORIASIS AND METABOLIC DISORDERS | MARIGEN S.A. (CH) | 2000-05-02 | — | — | US | disclosed |
| EP-0858331-A1 | SPONTANEOUSLY DISPERSIBLE CONCENTRATES OF STEROL ESTERS AND VITAMIN D DERIVATIVES WITH ANTIVIRAL, VIRUCIDAL AND/OR PARASITICIDAL EFFECT | MARIGEN S.A. (CH) | 1998-08-19 | — | — | EP | disclosed |
| WO-1998006390-A1 | SPONTANEOUSLY DISPERSIBLE CONCENTRATES OF STEROL ESTERS AND VITAMIN D DERIVATIVES WITH ANTIVIRAL, VIRUCIDAL AND/OR PARASITICIDAL EFFECT | MARIGEN S.A. (CH) | 1998-02-19 | — | — | WO | disclosed |
| US-5593691-A | DIESTERS AND UNSATURATED DIESTERS WITH COSMETICS, DRUGS AND TENSIDES | MARIGEN S.A. (CH) | 1997-01-14 | — | — | US | disclosed |
| US-4833132-A | 5-METHYL-3-SULFANILAMIDOISOOXAZOLE OR SALTS OR 2,4 DIAMINO PYRIMIDINE COMPOUNDS | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 1989-05-23 | — | — | US | disclosed |
| US-4833132-A | 5-METHYL-3-SULFANILAMIDOISOOXAZOLE OR SALTS OR 2,4 DIAMINO PYRIMIDINE COMPOUNDS | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 1989-05-23 | — | — | US | disclosed |
| US-4698335-A | Process for treating a warm-blooded animal to be subjected to radiotherapy | UNIVERSITY OF MEDICINE & DENTISTRY OF NEW JERSEY (US) | 1987-10-06 | — | — | US | disclosed |
| US-4151196-A | POTENTIATORS OF SULFONAMIDES, BACTERICIDES | HOFFMANN-LA ROCHE INC. (US) | 1979-04-24 | — | — | US | disclosed |
| US-4143227-A | FROM THE 2,4-DIAMINO-5-OXY OR HALOMETHYL-PYRIMIDINE AND A 1,2-DIALKOXY OR METHYLENEDIOXY-BENZENE IN AN ACID | HOFFMANN-LA ROCHE INC. (US) | 1979-03-06 | — | — | US | disclosed |
| US-4115650-A | Process for preparing 2,4-diamino-5-(substituted benzyl)-pyrimidines | HOFFMANN-LA ROCHE INC. (US) | 1978-09-19 | — | — | US | disclosed |
| US-4108888-A | REACTING BENZENE DERIVATIVE WITH AN ACRYLONITRILE IN THE PRESENCE OF AN ACID CATALYST | HOFFMANN-LA ROCHE INC. (US) | 1978-08-22 | — | — | US | disclosed |
| US-4033962-A | REACTING A BENZENE WITH AN ACRYLONITRILE AND GUANIDINE, POTENTIATORS OF SULFONAMIDES | HOFFMAN-LA ROCHE INC. (US) | 1977-07-05 | — | — | US | disclosed |
| US-3993761-A | 2,4-DIAMINO-5-(3-ALKOXY-4,5-METHYLENEDIOXYBENZYL)-PYRIMIDINES | HOFFMANN-LA ROCHE INC. (US) | 1976-11-23 | — | — | US | disclosed |
| US-3962435-A | ANTIBACTERIAL | HOFFMANN-LA ROCHE INC. (US) | 1976-06-08 | — | — | US | disclosed |
| US-RE28636-E | Antibacterial composition containing 5-methyl-3-sulfanilamidoisoxazole and trimethoxybenyl pyrimidine | — | 1975-12-02 | — | — | US | disclosed |